U.S. FDA approves bluebird bio’s gene therapy for a rare neurological disorder
-The U.S. Food and Drug Administration (FDA) has approved Bluebird
Neurological
U.S. Attorney’s Office Files Lawsuit Against Flint Neurological Centre P.C. For Violating the Rights of Individuals Who Have Disabilities
FLINT, MI — The U.S. Attorney’s Office for the Eastern